Role of IgE cells in the exacerbation and management of asthma: An experimental study

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Immunology

ISSN

2219-2824

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Immunol. Nov 18, 2025; 15(1): 111119
Published online Nov 18, 2025. doi: 10.5411/wji.v15.i1.111119

Table 2 Changes in key outcomes after 12 months

Outcome	Group A (standard therapy)	Group B (Anti-IgE + Standard)	P value
IgE reduction (%)	4.5	40.0	< 0.001
FEV1 improvement (%)	10.2	25.1	0.003
ACT score increase (points)	+3	+6	0.004
Exacerbation frequency change	-28	-65	0.001

FEV1: Forced expiratory volume in one second; ACT: Asthma control test.

Citation: Agussalim A, Citrawati C, Adam A. Role of IgE cells in the exacerbation and management of asthma: An experimental study. World J Immunol 2025; 15(1): 111119
URL: https://www.wjgnet.com/2219-2824/full/v15/i1/111119.htm
DOI: https://dx.doi.org/10.5411/wji.v15.i1.111119

Agussalim A, Citrawati C, Adam A. Role of IgE cells in the exacerbation and management of asthma: An experimental study. World J Immunol 2025; 15(1): 111119 [DOI: 10.5411/wji.v15.i1.111119]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.